Intracellular mechanisms in the activation of human platelets by low-density lipoproteins

Biochem J. 1987 Mar 1;242(2):559-64. doi: 10.1042/bj2420559.

Abstract

Low-density lipoproteins (LDL) have been shown to cause aggregation of human blood platelets at concentrations above 2 g of protein/l. The secretion of the contents of platelet dense granules was detected, but not that of the lysosomes. LDL gave rise to a mobilization of [3H]arachidonic acid from phospholipids and the appearance of products of the cyclo-oxygenase pathway after only 10 s. LDL-promoted aggregation was inhibited by both aspirin and indomethacin. There was an increase in 3H-labelled diacylglycerols and the phosphorylation of 47 kDa proteins. LDL therefore shares at least some of the mechanisms of stimulus/response coupling with those of other agonists.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arachidonic Acid
  • Arachidonic Acids / blood
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • Blood Proteins / metabolism
  • Diglycerides / blood
  • Humans
  • Intracellular Fluid / metabolism
  • Lipoproteins, LDL / pharmacology*
  • Phosphorylation
  • Platelet Aggregation / drug effects

Substances

  • 1,2-diacylglycerol
  • Arachidonic Acids
  • Blood Proteins
  • Diglycerides
  • Lipoproteins, LDL
  • Arachidonic Acid